Skip to main content
Premium Trial:

Request an Annual Quote

Texas VA Hospital Buys Cepheid’s Xpert MRSA Kit

NEW YORK (GenomeWeb News) — A Veterans Affairs hospital in Houston has bought a Cepheid test that detects antibiotic-resistant staphylococcus bacteria, the company said today.
 
Cepheid said the Michael E. DeBakey VA Medical Center has bought its GeneXpert MRSA kit, which tests for methicillin-resistant staphylococcus, the most common cause of nosocomial infections.
 
The MRSA also is resistant to oxacillin, penicillin, and amoxicillin, and affects those with weakened immune systems.
 
The MRSA test runs on Cepheid’s GeneXpert System, and can produce results in “just over an hour,” the company said.
 
The US Food and Drug Administration cleared the Xpert MRSA test on April 18.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.